Your browser doesn't support javascript.
loading
Protocadherin-1 serves as a prognostic biomarker and promotes pancreatic cancer progression by suppressing CD8+ T cell infiltration through CCL5-CCR5 axis.
Jiang, Zhichen; Zhang, Shaobo; Wang, Huiju; Hu, Chunfang; Li, Li; Zheng, Xiaohao; Mu, Yongrun; Wang, Fangxia; Mou, Yiping; Liu, Mingyang; Jin, Weiwei.
Afiliación
  • Jiang Z; Department of General Surgery, Devision of Gastroenterology and Pancreas, Zhejiang Provincial People's Hospital, Afliated People's Hospital, Hangzhou Medical College Hangzhou 310014, Zhejiang, China.
  • Zhang S; The Second School of Clinical Medicine, Zhejiang Chinese Medical University Hangzhou 310053, Zhejiang, China.
  • Wang H; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021, China.
  • Hu C; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021, China.
  • Li L; Department of General Surgery, Devision of Gastroenterology and Pancreas, Zhejiang Provincial People's Hospital, Afliated People's Hospital, Hangzhou Medical College Hangzhou 310014, Zhejiang, China.
  • Zheng X; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021, China.
  • Mu Y; Department of General Surgery, Devision of Gastroenterology and Pancreas, Zhejiang Provincial People's Hospital, Afliated People's Hospital, Hangzhou Medical College Hangzhou 310014, Zhejiang, China.
  • Wang F; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021, China.
  • Mou Y; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021, China.
  • Liu M; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021, China.
  • Jin W; Department of General Surgery, Devision of Gastroenterology and Pancreas, Zhejiang Provincial People's Hospital, Afliated People's Hospital, Hangzhou Medical College Hangzhou 310014, Zhejiang, China.
Am J Cancer Res ; 13(11): 5197-5217, 2023.
Article en En | MEDLINE | ID: mdl-38058826
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos